DeepLife uses deep learning to create digital twins of cells and predict, in silico, cells’ reaction to drugs, gene editing, or environmental perturbations. Their proprietary technology saves up to four years for the identification of molecular triggers that drive cells from a sick state to a healthy state. DeepLife wants to shape the future of bioengineering, starting today.